Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-01

AUTHORS

Shirish Gadgeel, Alice T Shaw, Fabrice Barlesi, Lucio Crinò, James Chih-Hsin Yang, Anne-Marie C Dingemans, Dong-Wan Kim, Filippo de Marinis, Mathias Schulz, Shiyao Liu, Ravindra Gupta, Ahmed Kotb, Sai-Hong Ignatius Ou

ABSTRACT

BACKGROUND: We evaluated the cumulative incidence rate (CIR) of central nervous system (CNS) and non-CNS progression in alectinib-treated patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) to determine the extent to which alectinib may treat or control CNS disease. METHODS: Patients with crizotinib-pretreated locally advanced or metastatic disease received alectinib 600 mg orally twice daily in two phase II trials. All patients underwent baseline imaging and regular centrally reviewed scans. RESULTS: At 24 months, the CIR for CNS progression was lower in patients without vs with baseline CNS metastases (8.0 vs 43.9%). Patients with baseline CNS disease and prior radiotherapy had a higher CIR of CNS progression than radiotherapy-naive patients (50.5 vs 27.4%) and a lower CIR of non-CNS progression (25.8 vs 42.5%). Adverse events leading to withdrawal occurred in 5.9% and 6.7% of patients with and without baseline CNS metastases, respectively. CONCLUSIONS: This analysis indicates a potential role for alectinib in controlling and preventing CNS metastases. More... »

PAGES

38

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2017.395

DOI

http://dx.doi.org/10.1038/bjc.2017.395

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092730269

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29149104


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Michigan\u2013Ann Arbor", 
          "id": "https://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Department of Internal Medicine, Division of Hematology and Oncology, The University of Michigan, 1500 E. Medical Center Drive, 7217CC, Ann Arbor, MI 48109, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gadgeel", 
        "givenName": "Shirish", 
        "id": "sg:person.0746475446.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746475446.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shaw", 
        "givenName": "Alice T", 
        "id": "sg:person.01310715077.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310715077.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aix-Marseille University", 
          "id": "https://www.grid.ac/institutes/grid.5399.6", 
          "name": [
            "Multidisciplinary Oncology and Therapeutic Innovations Department, Aix-Marseille University, Assistance Publique H\u00f4pitaux de Marseille, 58 Boulevard Charles Livon, Marseille 13284, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barlesi", 
        "givenName": "Fabrice", 
        "id": "sg:person.0727505441.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727505441.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori IRCCS Meldola, Meldola Province of Forl\u00ec-Cesena 47014, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crin\u00f2", 
        "givenName": "Lucio", 
        "id": "sg:person.01306124223.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306124223.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, No. 7, Zhongshan South Road, Zhongzheng District, Taipei City, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "James Chih-Hsin", 
        "id": "sg:person.012577717744.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012577717744.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Maastricht University Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.412966.e", 
          "name": [
            "Department of Pulmonology, Maastricht University Medical Center, PO Box 5800, Maastricht 6202 AZ, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dingemans", 
        "givenName": "Anne-Marie C", 
        "id": "sg:person.013257134617.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013257134617.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Seoul National University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Internal Medicine, Seoul National University Hospital, 101, Daehak-ro Jongno-GU, Seoul 03080, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Dong-Wan", 
        "id": "sg:person.01025773275.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025773275.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "European Institute of Oncology", 
          "id": "https://www.grid.ac/institutes/grid.15667.33", 
          "name": [
            "Division of Thoracic Oncology, European Institute of Oncology, Via Ripamonti 435, Milan 20146, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Marinis", 
        "givenName": "Filippo", 
        "id": "sg:person.01334166500.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334166500.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Roche (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418158.1", 
          "name": [
            "Genentech Inc., DNA Way, South San Francisco, CA 94080, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schulz", 
        "givenName": "Mathias", 
        "id": "sg:person.015271160407.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015271160407.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Roche (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418158.1", 
          "name": [
            "Genentech Inc., DNA Way, South San Francisco, CA 94080, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Shiyao", 
        "id": "sg:person.016066541007.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016066541007.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Roche (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418158.1", 
          "name": [
            "Genentech Inc., DNA Way, South San Francisco, CA 94080, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gupta", 
        "givenName": "Ravindra", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Roche (Switzerland)", 
          "id": "https://www.grid.ac/institutes/grid.417570.0", 
          "name": [
            "F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel 4070, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kotb", 
        "givenName": "Ahmed", 
        "id": "sg:person.014645675323.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014645675323.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, Irvine", 
          "id": "https://www.grid.ac/institutes/grid.266093.8", 
          "name": [
            "Department of Medicine, University of California Irvine School of Medicine, 1001 Health Sciences Road, Irvine, CA 92617, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ou", 
        "givenName": "Sai-Hong Ignatius", 
        "id": "sg:person.0726242546.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726242546.94"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2015.63.9443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004233920"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(15)00488-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009751711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.59.0539", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016158843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0000000000000029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031575860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2015.62.0138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042043060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.68.4639", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042566560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70142-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045815784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(17)30565-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085388300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1704795", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085898350"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-01", 
    "datePublishedReg": "2018-01-01", 
    "description": "BACKGROUND: We evaluated the cumulative incidence rate (CIR) of central nervous system (CNS) and non-CNS progression in alectinib-treated patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) to determine the extent to which alectinib may treat or control CNS disease.\nMETHODS: Patients with crizotinib-pretreated locally advanced or metastatic disease received alectinib 600\u2009mg orally twice daily in two phase II trials. All patients underwent baseline imaging and regular centrally reviewed scans.\nRESULTS: At 24 months, the CIR for CNS progression was lower in patients without vs with baseline CNS metastases (8.0 vs 43.9%). Patients with baseline CNS disease and prior radiotherapy had a higher CIR of CNS progression than radiotherapy-naive patients (50.5 vs 27.4%) and a lower CIR of non-CNS progression (25.8 vs 42.5%). Adverse events leading to withdrawal occurred in 5.9% and 6.7% of patients with and without baseline CNS metastases, respectively.\nCONCLUSIONS: This analysis indicates a potential role for alectinib in controlling and preventing CNS metastases.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.2017.395", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "118"
      }
    ], 
    "name": "Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC", 
    "pagination": "38", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d8f409023201e4a93ba69ccd36555c2c8bb3a76fe29c9c2754bbc0cf3518f690"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29149104"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2017.395"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092730269"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2017.395", 
      "https://app.dimensions.ai/details/publication/pub.1092730269"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000427.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc2017395"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.395'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.395'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.395'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2017.395'


 

This table displays all metadata directly associated to this object as RDF triples.

207 TRIPLES      21 PREDICATES      38 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2017.395 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nb86d0f49b09048bf91c568f9a29cae7d
4 schema:citation https://doi.org/10.1016/s0140-6736(17)30565-2
5 https://doi.org/10.1016/s1470-2045(13)70142-6
6 https://doi.org/10.1016/s1470-2045(15)00488-x
7 https://doi.org/10.1056/nejmoa1704795
8 https://doi.org/10.1097/jto.0000000000000029
9 https://doi.org/10.1200/jco.2014.59.0539
10 https://doi.org/10.1200/jco.2015.62.0138
11 https://doi.org/10.1200/jco.2015.63.9443
12 https://doi.org/10.1200/jco.2016.68.4639
13 schema:datePublished 2018-01
14 schema:datePublishedReg 2018-01-01
15 schema:description BACKGROUND: We evaluated the cumulative incidence rate (CIR) of central nervous system (CNS) and non-CNS progression in alectinib-treated patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) to determine the extent to which alectinib may treat or control CNS disease. METHODS: Patients with crizotinib-pretreated locally advanced or metastatic disease received alectinib 600 mg orally twice daily in two phase II trials. All patients underwent baseline imaging and regular centrally reviewed scans. RESULTS: At 24 months, the CIR for CNS progression was lower in patients without vs with baseline CNS metastases (8.0 vs 43.9%). Patients with baseline CNS disease and prior radiotherapy had a higher CIR of CNS progression than radiotherapy-naive patients (50.5 vs 27.4%) and a lower CIR of non-CNS progression (25.8 vs 42.5%). Adverse events leading to withdrawal occurred in 5.9% and 6.7% of patients with and without baseline CNS metastases, respectively. CONCLUSIONS: This analysis indicates a potential role for alectinib in controlling and preventing CNS metastases.
16 schema:genre research_article
17 schema:inLanguage en
18 schema:isAccessibleForFree true
19 schema:isPartOf Nbd806f21e7344c5bb11e6045824b75dd
20 Nead76de4b3de4bbba83063037bd31044
21 sg:journal.1017082
22 schema:name Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC
23 schema:pagination 38
24 schema:productId N01578a4553154ff29b4a41512eae7875
25 N223d22abc37e414b89c36447d962efec
26 N8eb0d7ec1f454247acf25a5856b88505
27 Na329122c2dd54039a2fe4fe6d1212fc7
28 Ne6324fd9c0da4ed5b99feba2c0abacdc
29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092730269
30 https://doi.org/10.1038/bjc.2017.395
31 schema:sdDatePublished 2019-04-11T00:04
32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
33 schema:sdPublisher N065cda912a7c4500a8e4de8f8b4e27a0
34 schema:url https://www.nature.com/articles/bjc2017395
35 sgo:license sg:explorer/license/
36 sgo:sdDataset articles
37 rdf:type schema:ScholarlyArticle
38 N01578a4553154ff29b4a41512eae7875 schema:name doi
39 schema:value 10.1038/bjc.2017.395
40 rdf:type schema:PropertyValue
41 N03bcffb94b884ac58740e555d3b357da rdf:first sg:person.015271160407.08
42 rdf:rest Nd6323648b476479da786c32bc3ac3d5a
43 N065cda912a7c4500a8e4de8f8b4e27a0 schema:name Springer Nature - SN SciGraph project
44 rdf:type schema:Organization
45 N1b530b0a325546c597338c9f79f4c3fd rdf:first sg:person.0726242546.94
46 rdf:rest rdf:nil
47 N206e741b88854dcf96c965a42e9c73b6 rdf:first sg:person.01334166500.43
48 rdf:rest N03bcffb94b884ac58740e555d3b357da
49 N223d22abc37e414b89c36447d962efec schema:name pubmed_id
50 schema:value 29149104
51 rdf:type schema:PropertyValue
52 N64f4b7f38de140ada3b97e441c490594 rdf:first sg:person.01310715077.67
53 rdf:rest Nbf8250f3b44a4300b71a29a724a6e344
54 N69bb05df43af457383215f573f02a9e3 rdf:first sg:person.012577717744.21
55 rdf:rest Ne4010c6283d745908df80372fe1771f6
56 N710e1f1adb854784b08261b7ab1b11a9 rdf:first sg:person.014645675323.09
57 rdf:rest N1b530b0a325546c597338c9f79f4c3fd
58 N85743add1ae64305a59aa7021940d303 schema:name Department of Oncology, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori IRCCS Meldola, Meldola Province of Forlì-Cesena 47014, Italy
59 rdf:type schema:Organization
60 N8eb0d7ec1f454247acf25a5856b88505 schema:name nlm_unique_id
61 schema:value 0370635
62 rdf:type schema:PropertyValue
63 Na028952e5f424b0688d1b38ff55ef768 rdf:first Nf300d8703587413cbd499b60a04afb66
64 rdf:rest N710e1f1adb854784b08261b7ab1b11a9
65 Na329122c2dd54039a2fe4fe6d1212fc7 schema:name dimensions_id
66 schema:value pub.1092730269
67 rdf:type schema:PropertyValue
68 Nb86d0f49b09048bf91c568f9a29cae7d rdf:first sg:person.0746475446.31
69 rdf:rest N64f4b7f38de140ada3b97e441c490594
70 Nbd806f21e7344c5bb11e6045824b75dd schema:issueNumber 1
71 rdf:type schema:PublicationIssue
72 Nbf8250f3b44a4300b71a29a724a6e344 rdf:first sg:person.0727505441.29
73 rdf:rest Ncab9bd4da2054ff7b6c51ae9e033f4b9
74 Ncab9bd4da2054ff7b6c51ae9e033f4b9 rdf:first sg:person.01306124223.21
75 rdf:rest N69bb05df43af457383215f573f02a9e3
76 Nd40fd91e333241b0a5eb5d54e4fa34fc rdf:first sg:person.01025773275.27
77 rdf:rest N206e741b88854dcf96c965a42e9c73b6
78 Nd6323648b476479da786c32bc3ac3d5a rdf:first sg:person.016066541007.11
79 rdf:rest Na028952e5f424b0688d1b38ff55ef768
80 Nd94b64908e844b30b20bdddeff235cb4 schema:name Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, No. 7, Zhongshan South Road, Zhongzheng District, Taipei City, Taiwan
81 rdf:type schema:Organization
82 Ne4010c6283d745908df80372fe1771f6 rdf:first sg:person.013257134617.84
83 rdf:rest Nd40fd91e333241b0a5eb5d54e4fa34fc
84 Ne6324fd9c0da4ed5b99feba2c0abacdc schema:name readcube_id
85 schema:value d8f409023201e4a93ba69ccd36555c2c8bb3a76fe29c9c2754bbc0cf3518f690
86 rdf:type schema:PropertyValue
87 Nead76de4b3de4bbba83063037bd31044 schema:volumeNumber 118
88 rdf:type schema:PublicationVolume
89 Nf300d8703587413cbd499b60a04afb66 schema:affiliation https://www.grid.ac/institutes/grid.418158.1
90 schema:familyName Gupta
91 schema:givenName Ravindra
92 rdf:type schema:Person
93 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
94 schema:name Medical and Health Sciences
95 rdf:type schema:DefinedTerm
96 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
97 schema:name Oncology and Carcinogenesis
98 rdf:type schema:DefinedTerm
99 sg:journal.1017082 schema:issn 0007-0920
100 1532-1827
101 schema:name British Journal of Cancer
102 rdf:type schema:Periodical
103 sg:person.01025773275.27 schema:affiliation https://www.grid.ac/institutes/grid.412484.f
104 schema:familyName Kim
105 schema:givenName Dong-Wan
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025773275.27
107 rdf:type schema:Person
108 sg:person.012577717744.21 schema:affiliation Nd94b64908e844b30b20bdddeff235cb4
109 schema:familyName Yang
110 schema:givenName James Chih-Hsin
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012577717744.21
112 rdf:type schema:Person
113 sg:person.01306124223.21 schema:affiliation N85743add1ae64305a59aa7021940d303
114 schema:familyName Crinò
115 schema:givenName Lucio
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306124223.21
117 rdf:type schema:Person
118 sg:person.01310715077.67 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
119 schema:familyName Shaw
120 schema:givenName Alice T
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310715077.67
122 rdf:type schema:Person
123 sg:person.013257134617.84 schema:affiliation https://www.grid.ac/institutes/grid.412966.e
124 schema:familyName Dingemans
125 schema:givenName Anne-Marie C
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013257134617.84
127 rdf:type schema:Person
128 sg:person.01334166500.43 schema:affiliation https://www.grid.ac/institutes/grid.15667.33
129 schema:familyName de Marinis
130 schema:givenName Filippo
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334166500.43
132 rdf:type schema:Person
133 sg:person.014645675323.09 schema:affiliation https://www.grid.ac/institutes/grid.417570.0
134 schema:familyName Kotb
135 schema:givenName Ahmed
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014645675323.09
137 rdf:type schema:Person
138 sg:person.015271160407.08 schema:affiliation https://www.grid.ac/institutes/grid.418158.1
139 schema:familyName Schulz
140 schema:givenName Mathias
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015271160407.08
142 rdf:type schema:Person
143 sg:person.016066541007.11 schema:affiliation https://www.grid.ac/institutes/grid.418158.1
144 schema:familyName Liu
145 schema:givenName Shiyao
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016066541007.11
147 rdf:type schema:Person
148 sg:person.0726242546.94 schema:affiliation https://www.grid.ac/institutes/grid.266093.8
149 schema:familyName Ou
150 schema:givenName Sai-Hong Ignatius
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726242546.94
152 rdf:type schema:Person
153 sg:person.0727505441.29 schema:affiliation https://www.grid.ac/institutes/grid.5399.6
154 schema:familyName Barlesi
155 schema:givenName Fabrice
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727505441.29
157 rdf:type schema:Person
158 sg:person.0746475446.31 schema:affiliation https://www.grid.ac/institutes/grid.214458.e
159 schema:familyName Gadgeel
160 schema:givenName Shirish
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746475446.31
162 rdf:type schema:Person
163 https://doi.org/10.1016/s0140-6736(17)30565-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085388300
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/s1470-2045(13)70142-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045815784
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/s1470-2045(15)00488-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009751711
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1056/nejmoa1704795 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085898350
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1097/jto.0000000000000029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031575860
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1200/jco.2014.59.0539 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016158843
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1200/jco.2015.62.0138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042043060
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1200/jco.2015.63.9443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004233920
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1200/jco.2016.68.4639 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042566560
180 rdf:type schema:CreativeWork
181 https://www.grid.ac/institutes/grid.15667.33 schema:alternateName European Institute of Oncology
182 schema:name Division of Thoracic Oncology, European Institute of Oncology, Via Ripamonti 435, Milan 20146, Italy
183 rdf:type schema:Organization
184 https://www.grid.ac/institutes/grid.214458.e schema:alternateName University of Michigan–Ann Arbor
185 schema:name Department of Internal Medicine, Division of Hematology and Oncology, The University of Michigan, 1500 E. Medical Center Drive, 7217CC, Ann Arbor, MI 48109, USA
186 rdf:type schema:Organization
187 https://www.grid.ac/institutes/grid.266093.8 schema:alternateName University of California, Irvine
188 schema:name Department of Medicine, University of California Irvine School of Medicine, 1001 Health Sciences Road, Irvine, CA 92617, USA
189 rdf:type schema:Organization
190 https://www.grid.ac/institutes/grid.32224.35 schema:alternateName Massachusetts General Hospital
191 schema:name Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
192 rdf:type schema:Organization
193 https://www.grid.ac/institutes/grid.412484.f schema:alternateName Seoul National University Hospital
194 schema:name Department of Internal Medicine, Seoul National University Hospital, 101, Daehak-ro Jongno-GU, Seoul 03080, South Korea
195 rdf:type schema:Organization
196 https://www.grid.ac/institutes/grid.412966.e schema:alternateName Maastricht University Medical Centre
197 schema:name Department of Pulmonology, Maastricht University Medical Center, PO Box 5800, Maastricht 6202 AZ, The Netherlands
198 rdf:type schema:Organization
199 https://www.grid.ac/institutes/grid.417570.0 schema:alternateName Roche (Switzerland)
200 schema:name F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel 4070, Switzerland
201 rdf:type schema:Organization
202 https://www.grid.ac/institutes/grid.418158.1 schema:alternateName Roche (United States)
203 schema:name Genentech Inc., DNA Way, South San Francisco, CA 94080, USA
204 rdf:type schema:Organization
205 https://www.grid.ac/institutes/grid.5399.6 schema:alternateName Aix-Marseille University
206 schema:name Multidisciplinary Oncology and Therapeutic Innovations Department, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, 58 Boulevard Charles Livon, Marseille 13284, France
207 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...